Detalhe da pesquisa
1.
Clinical Value of Timely Targeted Therapy for Patients With Advanced Non-Small Cell Lung Cancer With Actionable Driver Oncogenes.
Oncologist
; 2024 Feb 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-38417095
2.
Improving biomarker testing in advanced non-small-cell lung cancer and metastatic colorectal cancer: experience from a large community oncology network in the USA.
Future Oncol
; 19(20): 1397-1414, 2023 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-37318757
3.
Trilaciclib prior to chemotherapy and atezolizumab in patients with newly diagnosed extensive-stage small cell lung cancer: A multicentre, randomised, double-blind, placebo-controlled Phase II trial.
Int J Cancer
; 148(10): 2557-2570, 2021 May 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-33348420
4.
Overall Survival with Durvalumab after Chemoradiotherapy in Stage III NSCLC.
N Engl J Med
; 379(24): 2342-2350, 2018 12 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-30280658
5.
Patient-reported outcomes with durvalumab by PD-L1 expression and prior chemoradiotherapy-related variables in unresectable stage III non-small-cell lung cancer.
Future Oncol
; 17(10): 1165-1184, 2021 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-33583206
6.
Durvalumab after Chemoradiotherapy in Stage III Non-Small-Cell Lung Cancer.
N Engl J Med
; 377(20): 1919-1929, 2017 11 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-28885881
7.
Patient-reported outcomes with durvalumab after chemoradiotherapy in stage III, unresectable non-small-cell lung cancer (PACIFIC): a randomised, controlled, phase 3 study.
Lancet Oncol
; 20(12): 1670-1680, 2019 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-31601496
8.
Atezolizumab in combination with carboplatin plus nab-paclitaxel chemotherapy compared with chemotherapy alone as first-line treatment for metastatic non-squamous non-small-cell lung cancer (IMpower130): a multicentre, randomised, open-label, phase 3 trial.
Lancet Oncol
; 20(7): 924-937, 2019 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-31122901
9.
Phase II Study of Bendamustine and Ofatumumab in Elderly Patients with Newly Diagnosed Diffuse Large B-Cell Lymphoma Who Are Poor Candidates for R-CHOP Chemotherapy.
Oncologist
; 24(8): 1035-e623, 2019 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-31073022
10.
Erlotinib plus either pazopanib or placebo in patients with previously treated advanced non-small cell lung cancer: A randomized, placebo-controlled phase 2 trial with correlated serum proteomic signatures.
Cancer
; 124(11): 2355-2364, 2018 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29645086
11.
Symptomatic Pneumonitis With Durvalumab After Concurrent Chemoradiotherapy in Unresectable Stage III NSCLC.
JTO Clin Res Rep
; 5(3): 100638, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38455595
12.
Racial and Ethnic Inequities at the Practice and Physician Levels in Timely Next-Generation Sequencing for Patients With Advanced Non-Small-Cell Lung Cancer Treated in the US Community Setting.
JCO Oncol Pract
; 20(3): 370-377, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38194619
13.
Neoadjuvant Durvalumab Alone or Combined with Novel Immuno-Oncology Agents in Resectable Lung Cancer: The Phase II NeoCOAST Platform Trial.
Cancer Discov
; 13(11): 2394-2411, 2023 11 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37707791
14.
A Phase II Study Evaluating Orteronel, an Inhibitor of Androgen Biosynthesis, in Patients With Androgen Receptor (AR)-Expressing Metastatic Breast Cancer (MBC).
Clin Breast Cancer
; 22(3): 269-278, 2022 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-34824002
15.
Complementary Roles for Tissue- and Blood-Based Comprehensive Genomic Profiling for Detection of Actionable Driver Alterations in Advanced NSCLC.
JTO Clin Res Rep
; 3(9): 100386, 2022 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-36089920
16.
Clinical Outcomes for Plasma-Based Comprehensive Genomic Profiling Versus Standard-of-Care Tissue Testing in Advanced Non-Small Cell Lung Cancer.
Clin Lung Cancer
; 23(1): 72-81, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34782240
17.
Effects of Trilaciclib on Chemotherapy-Induced Myelosuppression and Patient-Reported Outcomes in Patients with Extensive-Stage Small Cell Lung Cancer: Pooled Results from Three Phase II Randomized, Double-Blind, Placebo-Controlled Studies.
Clin Lung Cancer
; 22(5): 449-460, 2021 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-33895103
18.
Durvalumab After Concurrent Chemoradiotherapy in Elderly Patients With Unresectable Stage III Non-Small-Cell Lung Cancer (PACIFIC).
Clin Lung Cancer
; 22(6): 549-561, 2021 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-34294595
19.
Impact of prior chemoradiotherapy-related variables on outcomes with durvalumab in unresectable Stage III NSCLC (PACIFIC).
Lung Cancer
; 151: 30-38, 2021 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33285469
20.
Nanoparticle Albumin-bound Paclitaxel Plus Carboplatin Induction Followed by Nanoparticle Albumin-bound Paclitaxel Maintenance in Squamous Non-Small-cell Lung Cancer (ABOUND.sqm): A Phase III Randomized Clinical Trial.
Clin Lung Cancer
; 22(1): 6-15.e4, 2021 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33097414